• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN ERGO II FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN ERGO II FOR TREATMENT PURPOSES Back to Search Results
Model Number MS9557
Device Problem Fluid Leak (1250)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
No further follow-up is planned. Evaluation summary: a female patient reported that, in (b)(6) and (b)(6) 2019, two drops of insulin leaked from the needle of her humapen ergo ii device after the injection was completed. She experienced abnormal blood glucose. The device was not returned for investigation (batch 1611d01, manufactured november 2016). Therefore, it could not be evaluated to confirm the complaint or presence of a malfunction. Malfunction unknown. A complaint history review of the batch did not identify any atypical findings with respect to dose accuracy or device leaking after injection issues. All humapen ergo ii devices are assessed for injection screw travel at the end of the manufacturing process, thus ensuring device functionality and dose accuracy with high probability. There is no evidence of improper use or storage.
 
Event Description
Lilly case id: (b)(6). This report is associated with product complaint: (b)(4). This spontaneous case, reported by a consumer who contacted the company to report an adverse event, concerned a (b)(6) year-old (b)(6) nationality) female patient. Medical history included allergic to penicillin. Concomitant medications included glucobay used for an unknown indication. The patient received insulin lispro protamine suspension 50%/insulin lispro 50% (rdna origin) injections (humalog 50, 100 u/ml), through cartridge via reusable pens (humapen luxura burgundy and humapen ergo ii), twice daily (bid) (morning 10,night 10) subcutaneously for the treatment of diabetes mellitus beginning on an unknown date. On an unknown date, after starting insulin lispro protamine suspension 50%/insulin lispro 50% therapy, her blood glucose was unstable. On an unknown date in 2017, she had been hospitalized. She was hospitalized every year for regulating blood glucose. The humapen luxura burgundy occurred a leaking out of the needle when the injection was finished (the amount of the leakage was unknown). She had no requirement for humapen luxura burgundy as it had been replaced (b)(4), lot unknown). The humapen ergo ii occurred that there was two drops of insulin leaking out of the needle after the injection was finished during (b)(6) 2019 to (b)(6) 2019. And he/she changed a new needle before each injection and did not store the humapen with the needle attached, and stored the humapen in the box (b)(4), lot 1611d01). Further hospitalization and discharge details were unknown. Information regarding any corrective treatment and event outcome was not provided. Therapy status with insulin lispro protamine suspension 50%/insulin lispro 50% was ongoing. The operator of the humapens and his or her training status was unknown. The general model humapen luxura burgundy duration of use and the suspect humapen luxura burgundy duration of use was not provided. The general model humapen ergo ii duration of use and the suspect humapen ergo ii duration of use was approximately two years as it was started in (b)(6) 2017. The humapen luxura burgundy was discontinued in (b)(6) 2017 and was not returned to the manufacturer, action taken with humapen ergo ii, which was manufactured in nov2016, was ongoing and was not returned to the manufacturer. The reporting consumer did not know if the event was related with insulin lispro protamine suspension 50%/insulin lispro 50% treatment. The reporting consumer did not provide relatedness of the event with humapen luxura burgundy and humapen ergo ii. Edit 06-apr-2020: upon external review of information received on 23-mar-2020. Updated humapen unknown body type to humapen luxura burgundy, updated pc details in narrative, updated euca fields for humapen luxura burgundy. No other changes to the case has been done. Update 10apr2020: additional information received on 09apr2020 from the global product complaint database. Entered device specific safety summaries (dsss). Updated the medwatch fields/ (b)(6) device information, and device return status to not returned to manufacturer for (b)(4) associated with unknown lot of a humapen luxura (burgundy) device and for (b)(4) associated with lot 1611d01 of humapen ergo ii device. Added date of manufacturer for (b)(4) associated with lot 1611d01 of humapen ergo ii device. Corresponding fields and narrative updated accordingly. Update 13apr2020: additional information received on 13apr2020 from the global product complaint database. No new information was added. Update 16apr2020: additional information received on 16apr2020 from the global product complaint database. No new information was added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameHUMAPEN ERGO II
Type of DeviceFOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis,
Manufacturer (Section G)
PHILLIPS-MEDISIZE CORPORATION
415 red cedar street
medical device manufacturing
menomonie,
Manufacturer Contact
chris davis
lilly corporate center
indianapolis, in 
MDR Report Key9988529
MDR Text Key193952727
Report Number1819470-2020-00035
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
K151686
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial
Report Date 04/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2020
Is this an Adverse Event Report? Yes
Device Operator Other
Device Model NumberMS9557
Device Lot Number1611D01
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received03/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/30/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 04/22/2020 Patient Sequence Number: 1
-
-